Leap Therapeutics Ownership 2024 | Who Owns Leap Therapeutics Now?
Institutional Ownership
33.00%
Insider Ownership
14.13%
Retail Ownership
52.87%
Institutional Holders
59.00
Leap Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -3,374 | -100.00% | - | Jun 30, 2023 |
| US BANCORP \DE\ | - | - | - | -6,100 | -100.00% | - | Jun 30, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -206 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -641 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -152,931 | -100.00% | - | Jun 30, 2023 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -1,537,227 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -177,739 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -3,210,802 | -100.00% | - | Jun 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -32,000 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -10,334 | -100.00% | - | Jun 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -21,240 | -100.00% | - | Jun 30, 2023 |
| TOMPKINS FINANCIAL CORP | - | - | - | -1,205 | -100.00% | - | Jun 30, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -455,200 | -100.00% | - | Jun 30, 2023 |
| COMMUNITY TRUST & INVESTMENT CO | - | - | - | -13,650 | -100.00% | - | Jun 30, 2023 |
| ARTAL GROUP S.A. | - | - | - | -4,000,000 | -100.00% | - | Jun 30, 2023 |
| D.A. DAVIDSON & CO. | - | - | - | -11,000 | -100.00% | - | Jun 30, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -29,678 | -100.00% | - | Jun 30, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -298,301 | -100.00% | - | Jun 30, 2023 |
| UBS OCONNOR LLC | - | - | - | -1,048,685 | -100.00% | - | Jun 30, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -2,012,180 | -100.00% | - | Jun 30, 2023 |
Leap Therapeutics's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -3,374 | -100.00% | - | Jun 30, 2023 |
| US BANCORP \DE\ | - | - | - | -6,100 | -100.00% | - | Jun 30, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -206 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -641 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -152,931 | -100.00% | - | Jun 30, 2023 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -1,537,227 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -177,739 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -3,210,802 | -100.00% | - | Jun 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -32,000 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -10,334 | -100.00% | - | Jun 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -21,240 | -100.00% | - | Jun 30, 2023 |
| TOMPKINS FINANCIAL CORP | - | - | - | -1,205 | -100.00% | - | Jun 30, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -455,200 | -100.00% | - | Jun 30, 2023 |
| COMMUNITY TRUST & INVESTMENT CO | - | - | - | -13,650 | -100.00% | - | Jun 30, 2023 |
| ARTAL GROUP S.A. | - | - | - | -4,000,000 | -100.00% | - | Jun 30, 2023 |
| D.A. DAVIDSON & CO. | - | - | - | -11,000 | -100.00% | - | Jun 30, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -29,678 | -100.00% | - | Jun 30, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -298,301 | -100.00% | - | Jun 30, 2023 |
| UBS OCONNOR LLC | - | - | - | -1,048,685 | -100.00% | - | Jun 30, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -2,012,180 | -100.00% | - | Jun 30, 2023 |
The largest Leap Therapeutics shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Leap Therapeutics (LPTX), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FOCUSED WEALTH MANAGEMENT, INC | - | - | - | -70 | -100.00% | - | Jun 30, 2023 |
| TCI WEALTH ADVISORS, INC. | - | - | - | -200 | -100.00% | - | Jun 30, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -206 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -641 | -100.00% | - | Jun 30, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -1,150 | -100.00% | - | Jun 30, 2023 |
| TOMPKINS FINANCIAL CORP | - | - | - | -1,205 | -100.00% | - | Jun 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,083 | -100.00% | - | Jun 30, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -3,374 | -100.00% | - | Jun 30, 2023 |
| US BANCORP \DE\ | - | - | - | -6,100 | -100.00% | - | Jun 30, 2023 |
| CAPTRUST FINANCIAL ADVISORS | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
| DONALDSON CAPITAL MANAGEMENT, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -10,008 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -10,334 | -100.00% | - | Jun 30, 2023 |
| D.A. DAVIDSON & CO. | - | - | - | -11,000 | -100.00% | - | Jun 30, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -12,670 | -100.00% | - | Jun 30, 2023 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -12,878 | -100.00% | - | Jun 30, 2023 |
| UBS GROUP AG | - | - | - | -13,064 | -100.00% | - | Jun 30, 2023 |
| COMMUNITY TRUST & INVESTMENT CO | - | - | - | -13,650 | -100.00% | - | Jun 30, 2023 |
| BAYSTATE WEALTH MANAGEMENT LLC | - | - | - | -15,385 | -100.00% | - | Jun 30, 2023 |
| VALEO FINANCIAL ADVISORS, LLC | - | - | - | -15,635 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Leap Therapeutics's largest institutional buyer is FOCUSED WEALTH MANAGEMENT, INC. The company purchased -70.00 stocks of LPTX, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | - | - | - | -7,425,570 | -100.00% | - | Jun 30, 2023 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -6,726,496 | -100.00% | - | Jun 30, 2023 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | - | - | - | -4,655,186 | -100.00% | - | Jun 30, 2023 |
| ARTAL GROUP S.A. | - | - | - | -4,000,000 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -3,210,802 | -100.00% | - | Jun 30, 2023 |
| 683 CAPITAL MANAGEMENT, LLC | - | - | - | -2,800,000 | -100.00% | - | Jun 30, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -2,012,180 | -100.00% | - | Jun 30, 2023 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -1,537,227 | -100.00% | - | Jun 30, 2023 |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | - | - | - | -1,535,816 | -100.00% | - | Jun 30, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -1,481,511 | -100.00% | - | Jun 30, 2023 |
| UBS OCONNOR LLC | - | - | - | -1,048,685 | -100.00% | - | Jun 30, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -1,046,712 | -100.00% | - | Jun 30, 2023 |
| SAMSARA BIOCAPITAL, LLC | - | - | - | -846,038 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -619,013 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -618,673 | -100.00% | - | Jun 30, 2023 |
| KNOTT DAVID M JR | - | - | - | -557,939 | -100.00% | - | Jun 30, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -455,200 | -100.00% | - | Jun 30, 2023 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | - | - | - | -453,441 | -100.00% | - | Jun 30, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -298,301 | -100.00% | - | Jun 30, 2023 |
| PLATINUM INVESTMENT MANAGEMENT LTD | - | - | - | -264,413 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Leap Therapeutics's biggest institutional seller is BAKER BROS. ADVISORS LP. The company sold -7.43M shares of LPTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | - | - | - | -7,425,570 | -100.00% | - | Jun 30, 2023 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -6,726,496 | -100.00% | - | Jun 30, 2023 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | - | - | - | -4,655,186 | -100.00% | - | Jun 30, 2023 |
| ARTAL GROUP S.A. | - | - | - | -4,000,000 | -100.00% | - | Jun 30, 2023 |
| VANGUARD GROUP INC | - | - | - | -3,210,802 | -100.00% | - | Jun 30, 2023 |
| 683 CAPITAL MANAGEMENT, LLC | - | - | - | -2,800,000 | -100.00% | - | Jun 30, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -2,012,180 | -100.00% | - | Jun 30, 2023 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -1,537,227 | -100.00% | - | Jun 30, 2023 |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | - | - | - | -1,535,816 | -100.00% | - | Jun 30, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -1,481,511 | -100.00% | - | Jun 30, 2023 |
| UBS OCONNOR LLC | - | - | - | -1,048,685 | -100.00% | - | Jun 30, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -1,046,712 | -100.00% | - | Jun 30, 2023 |
| SAMSARA BIOCAPITAL, LLC | - | - | - | -846,038 | -100.00% | - | Jun 30, 2023 |
| BLACKROCK INC. | - | - | - | -619,013 | -100.00% | - | Jun 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -618,673 | -100.00% | - | Jun 30, 2023 |
| KNOTT DAVID M JR | - | - | - | -557,939 | -100.00% | - | Jun 30, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -455,200 | -100.00% | - | Jun 30, 2023 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | - | - | - | -453,441 | -100.00% | - | Jun 30, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -298,301 | -100.00% | - | Jun 30, 2023 |
| PLATINUM INVESTMENT MANAGEMENT LTD | - | - | - | -264,413 | -100.00% | - | Jun 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -183,895 | -100.00% | - | Jun 30, 2023 |
| STATE STREET CORP | - | - | - | -177,739 | -100.00% | - | Jun 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -152,931 | -100.00% | - | Jun 30, 2023 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -50,700 | -100.00% | - | Jun 30, 2023 |
| MCADAM, LLC | - | - | - | -45,778 | -100.00% | - | Jun 30, 2023 |
| ANNANDALE CAPITAL, LLC | - | - | - | -40,000 | -100.00% | - | Jun 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -39,790 | -100.00% | - | Jun 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -35,483 | -100.00% | - | Jun 30, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -32,000 | -100.00% | - | Jun 30, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -29,678 | -100.00% | - | Jun 30, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -27,400 | -100.00% | - | Jun 30, 2023 |
| LPL FINANCIAL LLC | - | - | - | -26,375 | -100.00% | - | Jun 30, 2023 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -21,240 | -100.00% | - | Jun 30, 2023 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | - | - | - | -17,000 | -100.00% | - | Jun 30, 2023 |
| CNB BANK | - | - | - | -16,000 | -100.00% | - | Jun 30, 2023 |
| VALEO FINANCIAL ADVISORS, LLC | - | - | - | -15,635 | -100.00% | - | Jun 30, 2023 |
| BAYSTATE WEALTH MANAGEMENT LLC | - | - | - | -15,385 | -100.00% | - | Jun 30, 2023 |
| COMMUNITY TRUST & INVESTMENT CO | - | - | - | -13,650 | -100.00% | - | Jun 30, 2023 |
| UBS GROUP AG | - | - | - | -13,064 | -100.00% | - | Jun 30, 2023 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -12,878 | -100.00% | - | Jun 30, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -12,670 | -100.00% | - | Jun 30, 2023 |
| D.A. DAVIDSON & CO. | - | - | - | -11,000 | -100.00% | - | Jun 30, 2023 |
| MORGAN STANLEY | - | - | - | -10,334 | -100.00% | - | Jun 30, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -10,008 | -100.00% | - | Jun 30, 2023 |
| DONALDSON CAPITAL MANAGEMENT, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
| CAPTRUST FINANCIAL ADVISORS | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
| US BANCORP \DE\ | - | - | - | -6,100 | -100.00% | - | Jun 30, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -3,374 | -100.00% | - | Jun 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,083 | -100.00% | - | Jun 30, 2023 |
| TOMPKINS FINANCIAL CORP | - | - | - | -1,205 | -100.00% | - | Jun 30, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -1,150 | -100.00% | - | Jun 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -641 | -100.00% | - | Jun 30, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -206 | -100.00% | - | Jun 30, 2023 |
| TCI WEALTH ADVISORS, INC. | - | - | - | -200 | -100.00% | - | Jun 30, 2023 |
| FOCUSED WEALTH MANAGEMENT, INC | - | - | - | -70 | -100.00% | - | Jun 30, 2023 |
Leap Therapeutics's largest sold out institutional shareholder by shares sold is BAKER BROS. ADVISORS LP, sold -7.43M shares, valued at -, as of undefined.
Leap Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.12% | 288,301 | - | - | Mar 28, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.10% | 317,469 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 359,193 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.07% | 6,320 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.01% | 43,400 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.01% | 62,500 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.01% | 28,830 | - | - | Mar 28, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 15,196 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,141,141 | - | - | Mar 31, 2024 |
| Simplify Exchange Traded Funds | 0.01% | 375,976 | 375,976 | - | Mar 28, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.00% | 17,800 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 254,900 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 628,980 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 50,658 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 1,900 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.00% | 9,500 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.00% | 400 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 32,000 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 5,065 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 20,000 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 39,500 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 10,360 | 10,360 | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 3,200 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 3,700 | -2,800 | -43.08% | Mar 31, 2023 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 700 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,317 | - | - | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 12,500 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 8,328 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,584 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 1,240 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 11,719 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 159,447 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 7,618 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,838 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 1,872 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 2,727 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,256 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 445 | 162 | 57.24% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 200 | - | - | Mar 31, 2024 |
Leap Therapeutics's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 288.30K shares, compromising 0.12% of its total assets.
Leap Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 59 | -1.67% |
| 31 Dec, 22 | 60 | -13.04% |
| 30 Sep, 22 | 69 | -4.17% |
| 30 Jun, 22 | 72 | -16.28% |
| 31 Mar, 22 | 86 | 3.61% |
| 31 Dec, 21 | 83 | 33.87% |
| 30 Sep, 21 | 62 | 58.97% |
| 30 Jun, 21 | 39 | -11.36% |
| 31 Mar, 21 | 44 | -4.35% |
| 31 Dec, 20 | 46 | 21.05% |
| 30 Sep, 20 | 38 | -17.39% |
| 30 Jun, 20 | 46 | 100.00% |
| 31 Mar, 20 | 23 | 64.29% |
| 31 Dec, 19 | 14 | -22.22% |
| 30 Sep, 19 | 18 | 38.46% |
| 30 Jun, 19 | 13 | 18.18% |
| 31 Mar, 19 | 11 | -35.29% |
| 31 Dec, 18 | 17 | -26.09% |
| 30 Sep, 18 | 23 | 15.00% |
| 30 Jun, 18 | 20 | 5.26% |
| 31 Mar, 18 | 19 | 18.75% |
| 31 Dec, 17 | 16 | 100.00% |
| 30 Sep, 17 | 8 | 33.33% |
| 30 Jun, 17 | 6 | 20.00% |
| 31 Mar, 17 | 5 | - |
As of 31 Mar 23, 59 institutions are holding Leap Therapeutics's shares, representing a decrease of -1.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 42,678,838 | 30.93% |
| 31 Dec, 22 | 32,596,715 | -11.84% |
| 30 Sep, 22 | 36,973,754 | -1.64% |
| 30 Jun, 22 | 37,590,637 | -12.87% |
| 31 Mar, 22 | 43,141,400 | 0.60% |
| 31 Dec, 21 | 42,882,594 | 2.41% |
| 30 Sep, 21 | 41,873,496 | 93.90% |
| 30 Jun, 21 | 21,594,913 | -4.30% |
| 31 Mar, 21 | 22,565,316 | -7.37% |
| 31 Dec, 20 | 24,361,115 | -1.77% |
| 30 Sep, 20 | 24,800,729 | -11.64% |
| 30 Jun, 20 | 28,068,946 | 149.92% |
| 31 Mar, 20 | 11,231,064 | 239.04% |
| 31 Dec, 19 | 3,312,584 | -12.23% |
| 30 Sep, 19 | 3,774,131 | 44.90% |
| 30 Jun, 19 | 2,604,688 | 23.82% |
| 31 Mar, 19 | 2,103,544 | 8.88% |
| 31 Dec, 18 | 1,932,011 | -15.31% |
| 30 Sep, 18 | 2,281,180 | -13.84% |
| 30 Jun, 18 | 2,647,640 | 7.23% |
| 31 Mar, 18 | 2,469,039 | 514.27% |
| 31 Dec, 17 | 401,944 | 231.54% |
| 30 Sep, 17 | 121,235 | 60.12% |
| 30 Jun, 17 | 75,716 | -8.22% |
| 31 Mar, 17 | 82,497 | - |
Leap Therapeutics (LPTX) has 42.68M shares outstanding as of 31 Mar 23, up 30.93% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 33.00% | 3.98% |
| 31 Dec, 22 | 28.79% | 2.70% |
| 30 Sep, 22 | 32.65% | 2.96% |
| 30 Jun, 22 | 33.19% | 2.29% |
| 31 Mar, 22 | 38.09% | 2.65% |
| 31 Dec, 21 | 37.91% | 1.32% |
| 30 Sep, 21 | 53.53% | 6.70% |
| 30 Jun, 21 | 28.27% | 3.24% |
| 31 Mar, 21 | 29.54% | 1.75% |
| 31 Dec, 20 | 41.06% | 3.89% |
| 30 Sep, 20 | 32.49% | 1.13% |
| 30 Jun, 20 | 53.52% | 4.25% |
| 31 Mar, 20 | 35.51% | 16.50% |
| 31 Dec, 19 | 14.67% | 5.89% |
| 30 Sep, 19 | 15.78% | 12.20% |
| 30 Jun, 19 | 11.37% | 9.51% |
| 31 Mar, 19 | 10.93% | 5.86% |
| 31 Dec, 18 | 13.66% | 5.67% |
| 30 Sep, 18 | 15.52% | 4.78% |
| 30 Jun, 18 | 18.02% | 4.58% |
| 31 Mar, 18 | 19.83% | 145.18% |
| 31 Dec, 17 | 3.70% | 222.00% |
| 30 Sep, 17 | 1.29% | 198.52% |
| 30 Jun, 17 | 0.81% | 57.14% |
| 31 Mar, 17 | 1.19% | - |
As of 31 Mar 23, Leap Therapeutics is held by 33.00% institutional shareholders, representing a 3.98% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 24 | - |
| 31 Dec, 22 | 24 | -7.69% |
| 30 Sep, 22 | 26 | -3.70% |
| 30 Jun, 22 | 27 | -35.71% |
| 31 Mar, 22 | 42 | -22.22% |
| 31 Dec, 21 | 54 | 14.89% |
| 30 Sep, 21 | 47 | 291.67% |
| 30 Jun, 21 | 12 | -40.00% |
| 31 Mar, 21 | 20 | -35.48% |
| 31 Dec, 20 | 31 | 29.17% |
| 30 Sep, 20 | 24 | -36.84% |
| 30 Jun, 20 | 38 | 137.50% |
| 31 Mar, 20 | 16 | 300.00% |
| 31 Dec, 19 | 4 | -63.64% |
| 30 Sep, 19 | 11 | 37.50% |
| 30 Jun, 19 | 8 | -11.11% |
| 31 Mar, 19 | 9 | -10.00% |
| 31 Dec, 18 | 10 | -33.33% |
| 30 Sep, 18 | 15 | 15.38% |
| 30 Jun, 18 | 13 | 8.33% |
| 31 Mar, 18 | 12 | -7.69% |
| 31 Dec, 17 | 13 | 225.00% |
| 30 Sep, 17 | 4 | 33.33% |
| 30 Jun, 17 | 3 | -40.00% |
| 31 Mar, 17 | 5 | - |
24 institutional shareholders have increased their position in LPTX stock as of 31 Mar 23 compared to 24 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 15 | 15.38% |
| 31 Dec, 22 | 13 | -7.14% |
| 30 Sep, 22 | 14 | -22.22% |
| 30 Jun, 22 | 18 | 12.50% |
| 31 Mar, 22 | 16 | 128.57% |
| 31 Dec, 21 | 7 | - |
| 30 Sep, 21 | 7 | -41.67% |
| 30 Jun, 21 | 12 | -20.00% |
| 31 Mar, 21 | 15 | 114.29% |
| 31 Dec, 20 | 7 | -30.00% |
| 30 Sep, 20 | 10 | 900.00% |
| 30 Jun, 20 | 1 | - |
| 31 Mar, 20 | 1 | -66.67% |
| 31 Dec, 19 | 3 | 50.00% |
| 30 Sep, 19 | 2 | - |
| 30 Jun, 19 | - | - |
| 31 Mar, 19 | - | -100.00% |
| 31 Dec, 18 | 3 | -40.00% |
| 30 Sep, 18 | 5 | 150.00% |
| 30 Jun, 18 | 2 | - |
| 31 Mar, 18 | 2 | - |
| 31 Dec, 17 | - | -100.00% |
| 30 Sep, 17 | 1 | - |
| 30 Jun, 17 | 1 | - |
| 31 Mar, 17 | - | - |
15 institutional shareholders have reduced their position in LPTX stock as of 31 Mar 23 compared to 13 in the previous quarter (a 15.38% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 59 | -1.67% | 42,678,838 | 30.93% | 33.00% | 3.98% | 24 | - | 15 | 15.38% |
| 31 Dec, 22 | 60 | -13.04% | 32,596,715 | -11.84% | 28.79% | 2.70% | 24 | -7.69% | 13 | -7.14% |
| 30 Sep, 22 | 69 | -4.17% | 36,973,754 | -1.64% | 32.65% | 2.96% | 26 | -3.70% | 14 | -22.22% |
| 30 Jun, 22 | 72 | -16.28% | 37,590,637 | -12.87% | 33.19% | 2.29% | 27 | -35.71% | 18 | 12.50% |
| 31 Mar, 22 | 86 | 3.61% | 43,141,400 | 0.60% | 38.09% | 2.65% | 42 | -22.22% | 16 | 128.57% |
| 31 Dec, 21 | 83 | 33.87% | 42,882,594 | 2.41% | 37.91% | 1.32% | 54 | 14.89% | 7 | - |
| 30 Sep, 21 | 62 | 58.97% | 41,873,496 | 93.90% | 53.53% | 6.70% | 47 | 291.67% | 7 | -41.67% |
| 30 Jun, 21 | 39 | -11.36% | 21,594,913 | -4.30% | 28.27% | 3.24% | 12 | -40.00% | 12 | -20.00% |
| 31 Mar, 21 | 44 | -4.35% | 22,565,316 | -7.37% | 29.54% | 1.75% | 20 | -35.48% | 15 | 114.29% |
| 31 Dec, 20 | 46 | 21.05% | 24,361,115 | -1.77% | 41.06% | 3.89% | 31 | 29.17% | 7 | -30.00% |
| 30 Sep, 20 | 38 | -17.39% | 24,800,729 | -11.64% | 32.49% | 1.13% | 24 | -36.84% | 10 | 900.00% |
| 30 Jun, 20 | 46 | 100.00% | 28,068,946 | 149.92% | 53.52% | 4.25% | 38 | 137.50% | 1 | - |
| 31 Mar, 20 | 23 | 64.29% | 11,231,064 | 239.04% | 35.51% | 16.50% | 16 | 300.00% | 1 | -66.67% |
| 31 Dec, 19 | 14 | -22.22% | 3,312,584 | -12.23% | 14.67% | 5.89% | 4 | -63.64% | 3 | 50.00% |
| 30 Sep, 19 | 18 | 38.46% | 3,774,131 | 44.90% | 15.78% | 12.20% | 11 | 37.50% | 2 | - |
| 30 Jun, 19 | 13 | 18.18% | 2,604,688 | 23.82% | 11.37% | 9.51% | 8 | -11.11% | - | - |
| 31 Mar, 19 | 11 | -35.29% | 2,103,544 | 8.88% | 10.93% | 5.86% | 9 | -10.00% | - | -100.00% |
| 31 Dec, 18 | 17 | -26.09% | 1,932,011 | -15.31% | 13.66% | 5.67% | 10 | -33.33% | 3 | -40.00% |
| 30 Sep, 18 | 23 | 15.00% | 2,281,180 | -13.84% | 15.52% | 4.78% | 15 | 15.38% | 5 | 150.00% |
| 30 Jun, 18 | 20 | 5.26% | 2,647,640 | 7.23% | 18.02% | 4.58% | 13 | 8.33% | 2 | - |
| 31 Mar, 18 | 19 | 18.75% | 2,469,039 | 514.27% | 19.83% | 145.18% | 12 | -7.69% | 2 | - |
| 31 Dec, 17 | 16 | 100.00% | 401,944 | 231.54% | 3.70% | 222.00% | 13 | 225.00% | - | -100.00% |
| 30 Sep, 17 | 8 | 33.33% | 121,235 | 60.12% | 1.29% | 198.52% | 4 | 33.33% | 1 | - |
| 30 Jun, 17 | 6 | 20.00% | 75,716 | -8.22% | 0.81% | 57.14% | 3 | -40.00% | 1 | - |
| 31 Mar, 17 | 5 | - | 82,497 | - | 1.19% | - | 5 | - | - | - |
Leap Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Leap Therapeutics's stock was made by GILEAD SCIENCES, INC. on Apr 19 2024, selling - shares at - per share (valued at -).
Leap Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | 15 | - | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | 15 | 1 | 1500.00% |
| Q3 2022 | 12 | - | - |
| Q1 2022 | 12 | - | - |
| Q3 2021 | 4 | - | - |
| Q2 2021 | 6 | - | - |
| Q1 2021 | 20 | 4 | 500.00% |
| Q4 2020 | - | 1 | - |
| Q3 2020 | 10 | 1 | 1000.00% |
| Q2 2020 | 10 | 20 | 50.00% |
| Q1 2020 | 8 | 2 | 400.00% |
| Q2 2019 | 9 | - | - |
| Q1 2019 | 17 | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | 7 | 1 | 700.00% |
| Q2 2018 | 9 | - | - |
| Q4 2017 | 8 | 2 | 400.00% |
| Q1 2017 | 13 | 7 | 185.71% |
15 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Leap Therapeutics's insiders, as of Q3 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q3 2021 | 2 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | 8 | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | - | - | - |
| Q2 2018 | - | - | - |
| Q4 2017 | 8 | - | - |
| Q1 2017 | - | - | - |
As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Leap Therapeutics's stocks.
Leap Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| DAWN | Day One Biopharmaceuticals, Inc. |
| PDSB | PDS Biotechnology Corporation |
| HOOK | HOOKIPA Pharma Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| ELEV | Elevation Oncology, Inc. |
LPTX Ownership FAQ
Who Owns Leap Therapeutics?
Leap Therapeutics is owned by institutional shareholders (33.00%), insiders (14.13%), and public (52.87%). The largest institutional shareholder of Leap Therapeutics is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.12% of total shares).
Who are the major institutional shareholders of Leap Therapeutics?
Leap Therapeutics's major institutional shareholders are JPMORGAN CHASE & CO, US BANCORP \DE\, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, and NORTHERN TRUST CORP. The top five shareholders own together 0% of the company's share outstanding.
How many Leap Therapeutics shareholders are there?
As of Mar 2023, there are 59 institutional shareholders of Leap Therapeutics.
What percentage of Leap Therapeutics is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Leap Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).
What percentage of Leap Therapeutics is owned by US BANCORP \DE\?
As of Jun 2023, US BANCORP \DE\ holds 0 shares of Leap Therapeutics (LPTX), compromising 0% of the company, valued at $0.
What percentage of Leap Therapeutics is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ is the third largest holder of Leap Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).